On Tuesday, the Department of Justice (DOJ) announced that the world's largest biotechnology company Amgen has agreed to pay $24.9 million in order to settle allegations against it.

A clinical trial in Denmark has shed light on the fact that drug liraglutide can lead to weight loss in overweight or obese people with type-2 diabetes.

European approval has been received for a drug named `Jetrea' by the eye care division Alcon of Novartis AG.

In a new study released this Sunday, cangrelor has proved better as anti-clotting drug than the most commonly used drug for the purpose, plavix.

According to a new news report, Merck has finally named a new head of Research. Roger Perlmutter is now the new executive vice president and president of Merck Research Laboratories.

The European Medicines Agency (EMA) recently received a marketing authorization application (MAA) by pharmaceutical giant GlaxoSmithKline (GSK).

For the first time, seemingly, such kind of high-concentration sales push was there to be seen. It is being said that the aim was to guarantee results.

After an approval by the U. S. Food and Drug Administration (USFDA) for the generic version of the cancer drug Doxil, Sun Pharmaceutical Industries is active in the trade market.